Yanchun Lily Li

Yanchun “Lily” Li is a global entrepreneur and investor who has spent her career proving one idea: that lasting value flows through connection. She opened a channel between China and global capital markets by taking the first mainland Chinese pharmaceutical company that she cofounded public on the NYSE. Today she advises founders and families on IPOs, cross-border expansion, and the stewardship of wealth across generations through Harvard Wealth Strategy & Management. As a member of Harvard Kennedy School Dean’s council, a Trustee of the International Vaccine Institute, Vice Chair of the Global Solidarity Institute, and co-chair of Scholas Occurrentes, she bridges investment, business, education, and health at the institutions where global cooperation happens. Her core conviction: durable value emerges when we connect what stays apart.